Fig. 2From: Effect of mirabegron on cognitive function in elderly patients with overactive bladder: MoCA results from a phase 4 randomized, placebo-controlled study (PILLAR)Percentage of patients with indicated MoCA score change at week 12/EoT. EoT end of treatment, MoCA Montreal Cognitive AssessmentBack to article page